Recombinant Beijerinckia indica subsp. indica Serine hydroxymethyltransferase (glyA)

Shipped with Ice Packs
In Stock

Description

Genomic Context and Cloning

The glyA gene in B. indica subsp. indica is located on its 4.17 Mbp chromosome. Key genomic features:

  • GC Content: 57% (consistent with Alphaproteobacterial genomes) .

  • Gene Clustering: Not part of nitrogen fixation islands but shares metabolic versatility with other Rhizobiales .

Recombinant production involves:

  • Vector Systems: pUC18 and pVWEx2 for cloning and IPTG-inducible expression in E. coli .

  • Purification: Affinity chromatography (e.g., Ni-NTA for His-tagged variants) yields >85% pure enzyme .

Catalytic Activity

  • Primary Role: SHMT mediates serine/glycine interconversion, supporting nucleotide and methionine biosynthesis.

  • Substrate Specificity:

    • Preferential activity with L-serine over L-threonine (observed in homologs like Corynebacterium glutamicum SHMT) .

    • PLP-dependent mechanism, with conserved residues (e.g., His395, Phe473) influencing substrate binding .

Biotechnological Applications

ApplicationRelevance
Amino Acid ProductionEngineered glyA variants could optimize glycine/threonine ratios in industrial strains .
One-Carbon MetabolismCritical for metabolic engineering in biofuels or folate biosynthesis .
BioremediationPotential role in degrading toxic aldehydes via glycine-dependent pathways .

Research Gaps and Future Directions

  • Enzyme Kinetics: Detailed Km/kcat values for B. indica SHMT remain unpublished.

  • Structural Data: No crystal structures are available; molecular dynamics studies could elucidate substrate specificity .

  • Industrial Scaling: Stability under high substrate concentrations (~200 g/L) requires validation .

Product Specs

Form
Lyophilized powder. We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. For dry ice shipping, contact us in advance; extra fees apply.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
glyA; Bind_1225Serine hydroxymethyltransferase; SHMT; Serine methylase; EC 2.1.2.1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-433
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Beijerinckia indica subsp. indica (strain ATCC 9039 / DSM 1715 / NCIB 8712)
Target Names
glyA
Target Protein Sequence
MNAKVEVGQP AANSFFAANL ADADPEIAKA IELELGRQRH EIELIASENI VSKAVLEAQG SIMTNKYAEG YPGKRYYGGC QFVDIAENLA IERVRKLFDC QFANVQPNSG SQANQAVFLA LLQPGDVFMG LDLAAGGHLT HGSPVNLSGK WFKAVSYGVR QSDHLIDMDA VEALAKEHKP KLIIAGGSAY PRHWDFARFR AIADSVGAYF FVDMAHFAGL VAGGAHPSPF PHAHVVTSTT HKTLRGPRGG LVLTNDADIA KKINSAVFPG LQGGPLMHVI AAKAVAFGEA LRPDFRLYAQ QVVVNAGTLA SRLVEKGFAI SSGGTDNHLM LVDLRPKQLT GKAAEAALGR ASITCNKNGV PFDTASPFVT SGIRLGSPAA TSRGFGTKEF QDVADLIAET LDGLAKNGEE GNAAVEASVK ERAIALTQRF PIY
Uniprot No.

Target Background

Function
Catalyzes the reversible interconversion of serine and glycine using tetrahydrofolate (THF) as the one-carbon carrier. This is the major source of one-carbon groups for biosynthesis of purines, thymidylate, methionine, and other biomolecules. Also exhibits THF-independent aldolase activity on beta-hydroxyamino acids, producing glycine and aldehydes via a retro-aldol mechanism.
Database Links
Protein Families
SHMT family
Subcellular Location
Cytoplasm.

Q&A

What is Serine Hydroxymethyltransferase (glyA) and what is its primary function in bacterial metabolism?

Serine Hydroxymethyltransferase (SHMT), encoded by the glyA gene, is a ubiquitous pyridoxal 5'-phosphate (PLP)-dependent enzyme that catalyzes the reversible interconversion of serine and tetrahydrofolate (THF) to glycine and 5,10-methylene tetrahydrofolate (MTHF) . This reaction serves two critical metabolic functions in bacteria like Beijerinckia indica:

  • It provides glycine as a building block for protein synthesis

  • It generates MTHF, which serves as a major source of cellular one-carbon units essential for:

    • Purine biosynthesis

    • Thymidylate biosynthesis

    • Methionine biosynthesis

The enzyme can also catalyze THF-independent aldolytic cleavage, decarboxylation, and transamination reactions under certain conditions . In nitrogen-fixing bacteria like B. indica, one-carbon metabolism interconnects with nitrogen fixation pathways, potentially supporting the energetically demanding process of dinitrogen reduction.

How does the genomic context of glyA in Beijerinckia indica subsp. indica compare to other soil bacteria?

The complete genome of Beijerinckia indica subsp. indica provides valuable insights into the genomic neighborhood of glyA . Unlike many soil bacteria where glyA exists within operons related to one-carbon metabolism, analysis suggests Beijerinckia indica's glyA operates within a broader metabolic context related to its nitrogen-fixing capacity.

B. indica is phylogenetically closely related to facultative and obligate methanotrophs of the genera Methylocella and Methylocapsa , but unlike these relatives, B. indica does not oxidize methane or methanol . This genomic comparison reveals potential evolutionary tradeoffs between specialist methanotrophic lifestyles and B. indica's more generalist chemoorganotrophic lifestyle . The glyA gene likely plays a crucial role in this metabolic flexibility, providing one-carbon units for diverse biosynthetic pathways.

What structural features characterize the Beijerinckia indica SHMT enzyme?

While the specific crystal structure of B. indica SHMT has not been fully characterized in the provided search results, we can infer its likely structural properties based on related bacterial SHMTs, particularly the well-studied SHMT from Helicobacter pylori:

Beijerinckia indica SHMT likely contains:

  • A PLP-binding domain with a conserved lysine residue forming a Schiff base with the cofactor

  • Active site residues that coordinate the PLP-glycine-folate complex formation

  • Quaternary structure likely organized as a homotetramer (typical of bacterial SHMTs)

By comparison, the H. pylori SHMT apoprotein structure was determined at 2.8Å resolution, revealing a structural basis for the unexpectedly weak binding affinity of PLP . This structural insight might be relevant when expressing recombinant B. indica SHMT, as cofactor binding stability could impact purification and enzymatic assays.

What are the optimal expression systems for producing recombinant Beijerinckia indica SHMT?

Based on research with similar bacterial SHMTs, the following expression systems are recommended for recombinant B. indica SHMT production:

E. coli Expression Systems:

  • pQE60 Vector System: This IPTG-inducible system has been successfully used for complementation studies with bacterial SHMT genes . For B. indica SHMT, the full-length glyA gene should be cloned with appropriate restriction sites.

  • pET Vector Series: These systems typically yield high protein expression levels under T7 promoter control. Consider using BL21(DE3) or Rosetta(DE3) strains to address potential codon bias issues.

Expression Optimization Parameters:

  • Induction temperature: 16-25°C (lower temperatures often improve solubility)

  • IPTG concentration: 0.1-0.5 mM

  • Growth media: Supplementation with pyridoxal 5'-phosphate (50-100 μM) may improve holoenzyme formation

  • Expression time: 4-16 hours post-induction

For functional verification, complementation testing in an E. coli ΔglyA strain is recommended, similar to the approach documented with H. pylori SHMT .

What purification strategies maximize yield and stability of recombinant B. indica SHMT?

Recommended Purification Protocol:

  • Cell Lysis Buffer Composition:

    • 50 mM Tris-HCl (pH 7.5-8.0)

    • 150-300 mM NaCl

    • 10% glycerol

    • 1 mM EDTA

    • 0.1-0.2 mM PLP (critical for enzyme stability)

    • Protease inhibitors

  • Purification Steps:

    • Immobilized metal affinity chromatography (IMAC) for His-tagged constructs

    • Size exclusion chromatography to isolate tetrameric active forms

    • Optional ion exchange chromatography for increased purity

  • Stability Considerations:

    • Maintain PLP in all buffers (0.1 mM) to prevent apoenzyme formation

    • Include reducing agents (1-5 mM DTT or β-mercaptoethanol)

    • Store purified enzyme with 20-30% glycerol at -80°C

Given that H. pylori SHMT demonstrated unexpectedly weak binding affinity for PLP , particular attention should be paid to PLP concentration during purification of B. indica SHMT to maintain full activity.

How can researchers assess the functional activity of purified recombinant B. indica SHMT?

Recommended Enzymatic Assays:

  • Spectrophotometric Assay for Serine-to-Glycine Conversion:

    • Principle: Measures formation of MTHF by monitoring absorbance changes

    • Components:

      • 50 mM HEPES buffer (pH 7.5)

      • 0.2 mM THF

      • 1-2 mM L-serine

      • 0.1 mM PLP

      • Purified enzyme (5-20 μg)

    • Measurement: Increase in absorbance at 340 nm

  • Coupled Assay with MTHF Utilization:

    • Principle: Couples SHMT activity with thymidylate synthase

    • Advantage: Higher sensitivity for metabolic pathway analysis

  • Reverse Reaction Assay (Glycine-to-Serine):

    • Components:

      • 50 mM phosphate buffer (pH 7.4)

      • 1-5 mM glycine

      • 0.5 mM MTHF

      • 0.1 mM PLP

      • Purified enzyme

    • Detection: HPLC analysis of serine formation

For functional validation comparable to published studies, genetic complementation testing in an E. coli ΔglyA strain can confirm that the recombinant B. indica SHMT restores growth in minimal media lacking glycine .

How can researchers generate a targeted glyA knockout in Beijerinckia indica and what phenotypes should be expected?

Knockout Strategy:

  • Homologous Recombination Approach:

    • Design primers to amplify ~1 kb flanking regions upstream and downstream of glyA

    • Clone these regions into a suicide vector flanking an antibiotic resistance cassette

    • Transform B. indica with the construct and select for antibiotic resistance

    • Confirm gene disruption by PCR and sequencing

  • Alternative CRISPR-Cas9 Approach:

    • Design sgRNA targeting glyA

    • Use a CRISPR-Cas9 system adapted for Beijerinckia

    • Provide a repair template with antibiotic marker

Expected Phenotypes Based on Comparable Studies:

The H. pylori ΔglyA strain exhibited:

  • Significantly impaired growth (doubling time of 21 hours compared to 4 hours for wild-type)

  • Potential loss of certain virulence factors or metabolic capabilities

  • Glycine auxotrophy

For B. indica, expect:

  • Severe growth impairment in minimal medium

  • Potential glycine auxotrophy

  • Possible effects on nitrogen fixation capacity due to metabolic interconnections

  • Altered exopolysaccharide production, which is characteristic of B. indica

Supplementing growth media with glycine (1-5 mM) may partially restore growth but likely won't fully complement all metabolic deficiencies caused by glyA deletion.

What site-directed mutagenesis targets in B. indica SHMT would provide insight into substrate specificity and catalytic mechanism?

Based on conserved functional domains in bacterial SHMTs, the following site-directed mutagenesis targets would be informative:

Key Residues for Mutagenesis:

Residue TypePredicted FunctionSuggested MutationsExpected Effect
PLP-binding lysineForms Schiff base with PLPK→A, K→RComplete loss or severe reduction of catalytic activity
THF-binding residuesCoordinate folate bindingR→A, R→KAltered THF affinity without complete loss of function
Substrate specificity loopDictates amino acid specificityConservative substitutionsModified substrate preference
Dimer interface residuesStabilize quaternary structureHydrophobic→chargedDisruption of oligomeric state

Mutations at the PLP-binding site would be especially informative given the observation in H. pylori SHMT of unusually weak PLP binding . Exploring whether this characteristic is shared by B. indica SHMT could reveal evolutionary adaptations in cofactor interactions.

How does recombinant expression affect post-translational modifications of B. indica SHMT compared to native expression?

While specific data on B. indica SHMT post-translational modifications (PTMs) is not directly provided in the search results, several considerations are important when comparing recombinant and native enzyme:

  • Potential PTMs in Bacterial SHMTs:

    • Phosphorylation at serine/threonine residues

    • Potential for oxidative modifications at cysteine residues

    • Acetylation at lysine residues

  • Expression System Considerations:

    • E. coli expression systems may lack specific PTM machinery present in B. indica

    • Recombinant expression with tags (His, GST) may alter protein folding or oligomerization

  • Functional Validation:

    • Compare kinetic parameters between native (if extractable) and recombinant enzyme

    • Assess oligomerization state via size exclusion chromatography

    • Analyze PLP binding affinity, which may be influenced by the expression system

For the most accurate structural and functional studies, consider expressing the enzyme in a closely related bacterial host and performing mass spectrometry analysis to identify any PTMs present in the native but absent in recombinant protein.

How does B. indica SHMT compare functionally to SHMTs from methanotrophs like Methylocella and Methylocapsa?

Beijerinckia indica is phylogenetically closely related to facultative and obligate methanotrophs of the genera Methylocella and Methylocapsa , making comparative analysis of their SHMT enzymes particularly informative:

Comparative Analysis:

  • Metabolic Context Differences:

    • B. indica is a generalist chemoorganotroph that doesn't oxidize methane or methanol

    • Methylocella and Methylocapsa are specialized for growth on one-carbon compounds

    • These metabolic differences likely influence SHMT's role in one-carbon metabolism

  • Expected Functional Distinctions:

    • Substrate affinity: Methanotroph SHMTs may show optimized kinetics for one-carbon metabolism

    • Regulatory properties: Different allosteric regulation reflecting metabolic specialization

    • Cofactor binding: Potential adaptations in PLP binding sites

  • Evolutionary Implications:

    • Comparing B. indica SHMT with methanotroph homologs could reveal "genomic tradeoffs required for a specialist methanotrophic lifestyle compared to a more generalist chemoorganotrophic lifestyle"

    • Gene sequence and regulatory element analysis could identify selection pressures acting on glyA in different metabolic contexts

These comparative studies could provide insight into the evolution of methanotrophy as a metabolic lifestyle and the role of SHMT in metabolic specialization.

What roles does SHMT play in nitrogen-fixing bacteria compared to non-nitrogen fixers?

Beijerinckia indica is an N₂-fixing soil bacterium , making the role of SHMT in nitrogen-fixing metabolism particularly relevant:

SHMT in Nitrogen-Fixing Context:

  • Metabolic Integration:

    • One-carbon metabolism likely supports nitrogen fixation by providing:

      • Precursors for nucleotide synthesis (high demand during nitrogen fixation)

      • Methyl groups for regulatory processes

    • Potential connection between glycine/serine metabolism and glutamate/glutamine cycles central to nitrogen assimilation

  • Comparative Analysis with Other Nitrogen Fixers:

    • Azospirillum brasilense (another nitrogen-fixing rhizobacterium) shows complex regulatory responses to environmental cues

    • Similarly, B. indica SHMT may show regulatory adaptations coordinating one-carbon metabolism with nitrogen fixation demands

  • Research Approach:

    • Compare SHMT expression levels under nitrogen-fixing vs. non-fixing conditions

    • Analyze growth phenotypes of ΔglyA mutants under nitrogen-fixing conditions

    • Investigate potential protein-protein interactions between SHMT and nitrogen-fixation components

Understanding these connections could provide insight into how B. indica balances generalist heterotrophic metabolism with the specialized, energy-intensive process of nitrogen fixation.

How do genomic and proteomic analyses inform our understanding of SHMT evolution across bacterial species?

Comparative genomic and proteomic analyses provide valuable insights into SHMT evolution:

  • Genomic Context Analysis:

    • The complete genome sequence of B. indica enables analysis of glyA gene neighborhood

    • Comparing with related bacteria reveals evolutionary patterns in:

      • Gene synteny (conservation of gene order)

      • Regulatory elements controlling expression

      • Horizontal gene transfer events

  • Sequence-Structure-Function Relationships:

    • Comparing B. indica SHMT with structurally characterized bacterial SHMTs (like H. pylori SHMT ) reveals:

      • Conservation of catalytic residues across diverse bacteria

      • Lineage-specific adaptations in substrate binding regions

      • Correlations between genomic GC content and codon usage in glyA

  • Evolutionary Patterns:

    • SHMT has a "universal phylogenetic distribution" , making it valuable for understanding bacterial evolution

    • Comparison with SHMTs from related bacteria like H. pylori can reveal "insight into the evolution of methanotrophy as a metabolic lifestyle"

    • Analyzing positive selection patterns in SHMT across ecological niches could identify adaptive changes

This evolutionary perspective connects B. indica SHMT research to broader questions in bacterial metabolism and adaptation.

How can recombinant B. indica SHMT be used in synthetic biology applications for one-carbon metabolism engineering?

Recombinant B. indica SHMT holds significant potential for synthetic biology applications:

  • Metabolic Engineering for Enhanced One-Carbon Transfer:

    • Overexpression of optimized B. indica SHMT could increase flux through one-carbon metabolism

    • Applications in:

      • Enhanced production of nucleotides and amino acids in industrial strains

      • Improved carbon utilization efficiency in bioremediation applications

      • Engineered pathways for novel compound synthesis

  • Nitrogen Fixation Enhancement:

    • Co-expression of B. indica SHMT with nitrogen fixation genes could support:

      • Enhanced nitrogen fixation in agricultural applications

      • Improved resilience of engineered nitrogen-fixing systems

  • Bioremediation Applications:

    • Some strains of Beijerinckia "degrade aromatic compounds, and may be of use in petroleum purification or bioremediation"

    • Engineered SHMT variants could support metabolic pathways for enhanced degradation capacity

These applications leverage B. indica's natural metabolic versatility as a "generalist chemoorganotroph" combined with its nitrogen-fixing capability .

What experimental approaches can resolve contradictions in SHMT functional data across different bacterial species?

Resolving contradictory data requires systematic experimental approaches:

  • Standardized Assay Conditions:

    • Establish unified protocols for:

      • Buffer composition (pH, salt concentration)

      • Substrate concentrations

      • Cofactor (PLP) concentrations

      • Temperature and measurement parameters

  • Comprehensive Kinetic Analysis:

    • Determine full kinetic parameters for both forward and reverse reactions:

      • Km values for all substrates (serine, glycine, THF, MTHF)

      • kcat values under varying conditions

      • Inhibition constants for product inhibition

  • Structural Basis for Functional Differences:

    • Comparative structural analysis of SHMTs showing different properties

    • Chimeric enzyme construction to identify domains responsible for species-specific differences

    • Molecular dynamics simulations to understand conformational differences

  • Physiological Context:

    • Study enzyme behavior in cellular context through:

      • Metabolomics analysis of wild-type vs. glyA mutants

      • In vivo labeling studies with isotope-labeled substrates

      • Protein-protein interaction studies in native contexts

These approaches can reconcile contradictory findings by identifying experimental variables or physiological conditions responsible for observed differences.

How does PLP binding affinity in B. indica SHMT compare to other bacterial SHMTs, and what are the implications for enzyme engineering?

The search results highlight unusual PLP binding characteristics in H. pylori SHMT , making this an important comparative question for B. indica SHMT:

  • Comparative PLP Binding Analysis:

    • Determine PLP binding affinity constants (Kd) for B. indica SHMT

    • Compare with H. pylori SHMT's "unexpectedly weak binding affinity of PLP"

    • Analyze the structural basis for differences in PLP binding

  • Implications for Enzyme Engineering:

    • If B. indica SHMT shows similarly weak PLP binding:

      • Engineer variants with enhanced cofactor affinity

      • Explore potential advantages of weak binding (e.g., faster cofactor exchange)

    • If B. indica SHMT shows strong PLP binding:

      • Identify structural features responsible for enhanced binding

      • Apply these insights to improve other bacterial SHMTs

  • Methodological Considerations:

    • Spectroscopic methods to quantify PLP binding:

      • Fluorescence quenching

      • Circular dichroism

      • Isothermal titration calorimetry

    • Structural analysis:

      • X-ray crystallography of apoenzyme and holoenzyme forms

      • Molecular dynamics simulations of PLP binding/unbinding

The observation that "stabilization of the proposed inactive configuration using small molecules has potential to provide a specific way for inhibiting SHMT" suggests that understanding PLP binding dynamics could have implications beyond basic research to potential applications in enzyme inhibitor design.

What are the most common challenges in expressing and purifying active recombinant B. indica SHMT?

Researchers commonly encounter these challenges when working with recombinant SHMT:

  • Expression Challenges:

    • Inclusion body formation due to overexpression

    • Incomplete folding leading to inactive enzyme

    • Codon usage bias affecting translation efficiency

    • Toxicity to host cells

  • Purification Challenges:

    • PLP loss during purification steps

    • Oligomerization state heterogeneity

    • Co-purification of contaminating host proteins

    • Activity loss during concentration steps

  • Troubleshooting Approaches:

    • For inclusion bodies: Lower expression temperature (16-20°C) and IPTG concentration

    • For PLP loss: Add PLP (0.1-0.2 mM) to all purification buffers

    • For protein instability: Include glycerol (10-20%) and reducing agents

    • For low expression: Optimize codon usage or try different expression hosts

H. pylori SHMT studies revealed "unexpectedly weak binding affinity of PLP" , suggesting that maintaining PLP saturation throughout purification may be especially critical for B. indica SHMT as well.

How should researchers design experiments to study the role of B. indica SHMT in nitrogen fixation pathways?

An effective experimental design would include:

  • Expression Analysis Approaches:

    • qRT-PCR to measure glyA expression under nitrogen-fixing vs. non-fixing conditions

    • Promoter-reporter fusions to visualize expression patterns

    • Proteomics to quantify SHMT protein levels across growth conditions

  • Metabolic Flux Analysis:

    • Isotope labeling with 13C-serine or 13C-glycine to trace one-carbon metabolism

    • Metabolomics comparison between wild-type and glyA mutants

    • Correlation analysis between SHMT activity and nitrogenase activity

  • Genetic Interaction Studies:

    • Construction of double mutants affecting both nitrogen fixation and one-carbon metabolism

    • Conditional expression systems to modulate SHMT levels

    • Suppressor screens to identify genes that compensate for glyA deficiency

  • Experimental Controls:

    • Include non-nitrogen-fixing conditions as controls

    • Compare with non-nitrogen-fixing bacterial species

    • Use complemented mutant strains to confirm phenotype specificity

These approaches will help determine whether and how B. indica SHMT activity is integrated with the organism's nitrogen fixation capability, a key characteristic of this species .

What considerations are important when designing inhibitor screening assays for B. indica SHMT?

Developing effective inhibitor screening assays requires:

  • Assay Design Principles:

    • High-throughput compatibility

    • Sensitivity to partial inhibition

    • Minimal false positives/negatives

    • Physiologically relevant conditions

  • Recommended Screening Approaches:

    • Primary spectrophotometric assay monitoring MTHF formation

    • Secondary assays:

      • PLP binding displacement assays

      • Thermal shift assays to detect stabilization/destabilization

      • Structural studies (X-ray, cryo-EM) for binding mode confirmation

  • Inhibitor Classification Strategy:

    • PLP-competitive inhibitors

    • Substrate (serine/glycine) competitive inhibitors

    • Allosteric inhibitors

    • Oligomerization disruptors

  • Validation Methods:

    • Counter-screening against human SHMT to assess selectivity

    • Cell-based assays in B. indica and model organisms

    • Testing in nitrogen-fixing conditions to assess physiological relevance

The observation that "stabilization of the proposed inactive configuration using small molecules has potential to provide a specific way for inhibiting SHMT" provides a specific direction for inhibitor design that could be explored for B. indica SHMT.

What are the most promising future research directions for B. indica SHMT studies?

The most promising research directions include:

  • Structural Biology:

    • Determination of high-resolution crystal structure of B. indica SHMT

    • Comparative analysis with related bacterial SHMTs

    • Dynamic studies of conformational changes during catalysis

  • Metabolic Integration:

    • Systems biology approaches to understand SHMT's role in B. indica's metabolism

    • Intersection between one-carbon metabolism and nitrogen fixation

    • Metabolic flux analysis under varying environmental conditions

  • Biotechnological Applications:

    • Engineering B. indica SHMT for enhanced catalytic efficiency

    • Development of B. indica strains with optimized one-carbon metabolism

    • Application in bioremediation of aromatic compounds

  • Evolutionary Studies:

    • Comparative genomics between B. indica and related methanotrophs

    • Exploring "genomic tradeoffs required for a specialist methanotrophic lifestyle compared to a more generalist chemoorganotrophic lifestyle"

    • Reconstruction of evolutionary history of SHMT across bacterial lineages

These directions leverage B. indica's unique position as a nitrogen-fixing soil bacterium that is closely related to methanotrophs but follows a more generalist metabolic strategy .

How can contradictory findings about SHMT function across bacterial species be reconciled through systematic research approaches?

To reconcile contradictory findings, researchers should implement:

  • Standardized Experimental Framework:

    • Establish common protocols for enzyme assays

    • Define standard growth and expression conditions

    • Create shared reference materials (plasmids, strains)

    • Develop validation criteria for functional claims

  • Comprehensive Characterization:

    • Full kinetic parameter determination

    • Structural studies across multiple species

    • Phylogenetic analysis correlated with functional differences

    • Systematic mutagenesis to identify determinants of species-specific behaviors

  • Collaborative Research Models:

    • Multi-laboratory studies using identical protocols

    • Central repositories for raw data sharing

    • Meta-analysis of published results with standardized metrics

  • Contextual Understanding:

    • Consider ecological niches of source organisms

    • Account for metabolic networks specific to each species

    • Examine gene regulation in native contexts

By implementing these approaches, researchers can determine whether contradictions represent genuine biological differences or experimental artifacts, advancing our understanding of SHMT function across bacterial diversity.

What interdisciplinary approaches could enhance our understanding of B. indica SHMT's role in soil microbial communities?

Interdisciplinary approaches that would enhance our understanding include:

  • Metagenomics and Environmental Microbiology:

    • Survey glyA variants in soil microbiomes

    • Correlate SHMT sequence variation with soil properties

    • Study horizontal gene transfer patterns of glyA in soil communities

  • Plant-Microbe Interactions:

    • Investigate B. indica SHMT activity during plant root colonization

    • Explore metabolic exchange between plants and B. indica involving one-carbon units

    • Examine potential roles in plant growth promotion

  • Biogeochemical Cycling:

    • Connect one-carbon metabolism to nitrogen and carbon cycling in soils

    • Analyze SHMT's role in B. indica's ability to "fix nitrogen" in various soil conditions

    • Explore connections to degradation of "aromatic compounds" in soil environments

  • Synthetic Ecology:

    • Design microbial consortia with engineered B. indica SHMT variants

    • Test ecological fitness under controlled environmental parameters

    • Model metabolic interactions between community members

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.